Keywords: synthelabo, sales, forecast, rise, provisional, nine-month, french
Synthelabo 1998 Sales Forecast To Rise 8%
Article | 14 October 1998
Provisional nine-month 1998 sales at French drugmaker Synthelabo rose6.7% on a comparable basis to 9.17 billion French francs ($1.65 billion), and for the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
